Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Extracranial Venous abnormalities: A true pathological finding in patients with multiple sclerosis or an anatomical variant?
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice.
In vitro modeling of central nervous system myelination and remyelination.
Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Parent-of-origin effect in multiple sclerosis: observations in half-siblings.
Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia.
Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Immunology 2012
Unusual case of gastroparesis leading to severe gastromegaly with demyelinating disease as a rare cause.
The effect of Nintendo(R) Wii(R) on balance in people with multiple sclerosis: a pilot randomized control study.
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
Memory rehabilitation for people with multiple sclerosis.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Normal outcome of pregnancy with ongoing treatment with natalizumab.
Demyelination: the role of reactive oxygen and nitrogen species.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity.
Phenytoin (Dilantin) and acupuncture therapy in the treatment of intractable oral and facial pain.
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.
Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta.
Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
[Multiple sclerosis : actuality and therapeutic prospects].

Pages